The purpose of this study was to screen for reduced susceptibility against imipenem and the presence of the New Delhi metallo-b-lactamase-1 (NDM-1) gene in a collection of Enterobacteriaceae , three Klebsiella pneumoniae isolates (2.4 %) were resistant to imipenem and were positive for bla NDM-1 . All these NDM-1-producing strains were isolated in 2008 and were resistant to all antibiotics tested except for tigecycline and colistin. All three isolates were positive for bla OXA-1 group, bla CTX-M-1 group (bla CTX-M-15 ) and bla SHV genes, whilst two isolates were positive for 16S rRNA methylase (armA) and qnr (qnrB) genes. One isolate was positive for the bla CMY gene and one for the rmtB gene. The bla NDM-1 gene was located on a conjugative plasmid of~23-24 MDa. The PFGE patterns of the isolates were different from each other. This study highlights the occurrence of NDM-1-producing organisms in Bangladesh in 2008. The clonal diversity of the isolates and the transferability of bla NDM-1 plasmids suggest a wider distribution of NDM-1-producing bacteria in Bangladesh.
INTRODUCTION
The increasing incidence of infections caused by New Delhi metallo-b-lactamase-1 (NDM-1)-producing Enterobacteriaceae has led to serious concern among the international medical community (Kumarasamy et al., 2010) . Many case reports and surveillance studies have revealed a strong association between the colonization of NDM-1-carrying Enterobacteriaceae and prior hospitalization in and/or travel to the Indian subcontinent (Perry et al., 2011) . Although NDM-1 was first recorded in 2008 in a Klebsiella pneumoniae strain isolated from a Swedish patient who had travelled to New Delhi (Yong et al., 2009) , a recent report suggests that isolates producing the NDM-1 enzyme were disseminated in Indian healthcare facilities as early as 2006 (Castanheira et al., 2011) .
In a previous surveillance study during 1 month in October 2010, we found that 3.5 % of Gram-negative bacteria tested in the study were positive for bla NDM-1 and were resistant to multiple antibiotics (Islam et al., 2012) . The aim of the present study was to determine the occurrence of NDM-1-producing organisms in various collections of Enterobacteriaceae isolated prior to October 2010.
METHODS
Bacterial isolates. We screened a total of 2006 Enterobacteriaceae for imipenem susceptibility. The isolates were obtained from a collection of strains available at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Determination of MICs. The MICs of imipenem, meropenem, piperacillin-tazobactam, cefotaxime, ceftriaxone, ceftazidime, cefpirome, aztreonam, ciprofloxacin, gentamicin, tobramycin, amikacin, minocycline, tigecycline and colistin were determined by Etest (bioMérieux) following CSLI guidelines. We used a metallo-blactamase (MBL) Etest (bioMérieux) to screen for MBL production.
PCR detection of resistance genes. Isolates were screened for the presence of the bla NDM-1 gene by PCR (Islam et al., 2012) . The amplified products (465 bp) were sequenced using an ABI PRISM 310 sequencer (Applied Biosystems). PCR was also performed to detect the genes bla TEM , bla SHV , bla OXA-1 group, bla OXA-48 , bla CTX-M-1 group, bla CTX-M-2 group, bla CTX-M-8 group, bla CTX-M-9 group, bla CTX-M-15 , bla VIM and bla CMY , and the 16S RNA methylase genes (rmtC, rmtB and armA) and qnr genes (qnrA, qnrB and qnrS). The primer sequences used in the PCRs are listed in Table 1 .
Plasmid profile analysis and conjugation assays. Plasmid DNA was prepared according to the rapid alkaline lysis method and separated by horizontal electrophoresis in 0.7 % agarose gels in TBE buffer at room temperature at 100 V (50 mA) for 3 h (Talukder et al., 2002) . The size of unknown plasmids was determined by comparing their band patterns obtained by agarose gel electrophoresis with those obtained with plasmids used as standards. The plasmids Sa (23 MDa), RP4 (34 MDa) and R1 (62 MDa), a strain containing pDK9
(140 MDa) and a plasmid of 105 MDa, and E. coli V517 with plasmids of 1.4, 1.8, 2.0, 2.6, 3.4, 3.7, 4.8 and 35.8 MDa were used as standards (Macrina et al., 1978) . Conjugation was carried out by both broth-mating and filter-mating assays at 30 uC using NDM-1-producing isolates as donor and azide-resistant E. coli J53 as recipient. Transconjugant selection was performed on MacConkey agar containing meropenem (0.5 mg l 21 ) and sodium azide (100 mg l 21 ). Transconjugants were tested for bla NDM-1 as well as other genes, as described above, by PCR. The MICs of imipenem and meropenem against all transconjugants were determined as described above. Plasmid analysis of the transconjugants was carried out as described previously (Talukder et al., 2002) . The plasmids were subsequently transferred to nylon membrane and Southern blot hybridization was carried out using a digoxygenin-labelled bla NDM-1 probe according to the manufacturer's instructions (Roche Diagnostics).
Genetic fingerprinting. Genomic DNA was prepared in agarose blocks and digested with the restriction enzyme XbaI (New England Biolabs). DNA fragments were separated by PFGE on a CHEF-MAPPER apparatus (Bio-Rad) according to the PulseNet program developed for E. coli (Ribot et al., 2006) . Analysis of TIFF images was carried out using BioNumerics software (Applied Maths) using the dice coefficient and UPGMA to generate dendrograms with 1.0 % tolerance values. Normalized PFGE patterns (bundle files) of the three K. pneumoniae were compared with those of the bla NDM-1 -positive K. pneumoniae isolates from our previous studies to determine clonal relationships (Islam et al., 2012) . ) and all were positive for the bla NDM-1 gene. All three isolates were isolated between October and November 2008, with two being isolated from urine samples of patients with urinary tract infections and one from a tracheal aspirate of a patient with a respiratory tract infection. The patients attended three different hospitals. We did not find any epidemiological relationship among the three patients.
RESULTS

Detection of NDM-1-producing micro-organisms
MICs
The MICs of imipenem against bla NDM-1 -positive isolates ranged from 12 to 32 mg l
21
. All three isolates were resistant to the antibiotics amikacin, aztreonam, ceftazidime, ceftriaxone, cefotaxime, cefpirome, gentamicin, piperacillin/ tazobactam, minocycline, ciprofloxacin and tobramycin but were susceptible to tigecycline (MIC ¡2 mg l
) and colistin (MIC ¡2 mg l 21 ) ( Table 2 ). All three also tested positive for MBL with the MBL Etest.
PCR detection of resistance genes
The genes for bla CTX-M group 1, bla CTX-M-15 , bla OXA-1 group and bla SHV were detected in the three bla NDM-1 -positive K. pneumoniae isolates. The bla CMY gene was detected in one isolate. None was positive for bla TEM , bla VIM , bla CTX-M-2 group, bla CTX-M-8 group, bla CTX-M-9 group and bla OXA-48 . Two K. pneumoniae isolates (K1 and K16) were positive for the 16S RNA methylase gene armA, whilst the other isolate (K21) was positive for rmtB. We also detected qnrB in K1 and K16 (Table 2) .
Plasmid profile analysis and conjugation assays
All three bla NDM-1 -positive isolates carried multiple plasmids ranging from 1.4 to 140 MDa and their plasmid profiles were different from each other (Fig. 1 ). Transconjugants were created in E. coli J53 from all three strains and only a single plasmid of~23-24 MDa was transferred. All transconjugants carrying this plasmid were positive for the bla NDM-1 gene and were resistant to imipenem (MIC range of 12-16 mg ml
21
) and meropenem (MIC range of 6-8 mg ml
). The location of this gene was confirmed in this plasmid by Southern blot hybridization (Fig. 1) . Resistance to the third-generation cephalosporins ceftriaxone, cefotaxime and ceftazidime and to piperacillin/ tazobactam was co-transferred by the conjugative plasmid. Transconjugants remained susceptible to gentamicin, ciprofloxacin and aztreonam. Hence, resistance factors for these antibiotics were not transferred via the plasmid (Table 3) . 
Genetic fingerprinting
The PFGE patterns of the bla NDM-1 -positive isolates were completely different from each other. We compared these PFGE patterns with those of seven bla NDM-1 -positive K. pneumoniae strains reported previously from Bangladesh. All patterns differed significantly and therefore appeared to be genetically and epidemiologically unrelated (Fig. 2) .
DISCUSSION
In our previous study, we found that around 3.5 % of Gram-negative organisms in Bangladesh produced NDM-1 based on a prospective surveillance of consecutive clinical samples tested in 2010 (Islam et al., 2012) , the same year that an article by Kumarasamy et al. (2010) attracted worldwide attention. Subsequent studies reported that the emergence of NDM-1 has not occurred recently but dates back a number of years. For instance, an Acinetobacter baumannii strain isolated in 2007 from a patient in Germany was detected as bla NDM-1 positive. Isolates producing NDM-1 were circulating in Indian healthcare facilities as early as 2006 (Castanheira et al., 2011) . According to this study, NDM-1-carrying bacteria have been circulating in Bangladesh since 2008, and all isolates were identified preliminarily as ESBL producers. Although we tested a collection of ESBLproducing strains that have been collected since 2003, these isolates were not obtained from any systematic surveillance study. Therefore, it might be possible that NDM-1-producing isolates in Bangladesh were circulating earlier than 2008, which could be essentially the same period as that reported by the Indian study. In this study, we tested a considerable number of enteric pathogens, particularly E. coli and Shigella spp. isolated from hospitalized patients with diarrhoea and from healthy controls from both rural and urban areas of Bangladesh. The purpose was to determine the occurrence of NDM-1-producing organisms among enteropathogens that are commonly isolated in Bangladesh and are relatively more susceptible to acquiring extrachromosomal DNA through horizontal gene transfer. We did not find any E. coli or Shigella sp. that was positive for bla NDM-1 . Recently, Shigella boydii and Vibrio cholerae isolates carrying bla NDM-1 , along with a number of non-fermentative Gramnegative bacteria, were isolated from environmental sources in India (Walsh et al., 2011) . It is possible that these organisms acquired bla NDM-1 from other Gram-negative organisms in the environment through horizontal gene transmission. No study has yet been carried out on the occurrence of NDM-1-producing organisms in different environments in Bangladesh.
All bla NDM-1 -positive isolates co-harboured the bla CTX-M-15 , bla OXA-1 and bla SHV genes. Co-occurrence of 16S RNA methylase genes encoding broad-spectrum aminoglycoside resistance was also observed and was of different types (armA, rmtB and rmtC). Among the plasmid-mediated quinolone resistance genes, a qnrB gene was identified in two strains. According to previous studies, the acquisition of uncommon and unrelated broad-spectrum resistance genes in NDM-1-producing strains suggests that they have been selected by broad-spectrum antibiotics (Poirel et al., 2011a) . The bla NDM-1 gene was located on a single plasmid of~23-24 MDa for all three strains. In our previous study, we found that bla NDM-1 was carried by conjugative plasmids ranging in size from 60 to 100 MDa (Islam et al., 2012) . According to Solé et al. (2011) , bla NDM-1 plasmids can differ widely in size from 50 to 200 kb (~30-120 MDa). Another study reported that bla NDM-1 plasmids can vary from 50 to 450 kb (~30-275 MDa) (Castanheira et al., 2011) . The PFGE patterns of the three K. pneumoniae isolates were different from each other and were also different from the patterns obtained from previously isolated NDM-1-producing K. pneumoniae in Bangladesh, indicating multiple acquisitions of resistant isolates, even over such a short time period (OctoberNovember 2008) .
This study highlights the early occurrence of NDM-1-producing organisms in Bangladesh in 2008. The clonal diversity of the isolates and the transferability of bla NDM-1 plasmids suggest a wider distribution of NDM-1-producing bacteria in the community. Rigorous screening for NDM and other MBLs in ESBL-producing organisms is warranted for early diagnosis and management of patients in this part of the world.
